N-[(2,2-Dimethyl-4,6-dioxo-1,3-dioxan-5-ylidene)methyl]-2,2-dimethylpropanamide

Catalog No. :
ACYOET874
CAS No. :
175728-10-6
Molecular Formula :
C12H17NO5
Molecular Weight :
255.27

IUPAC Name:N-((2,2-dimethyl-4,6-dioxo-1,3-dioxan-5-ylidene)methyl)pivalamide

N-[(2,2-Dimethyl-4,6-dioxo-1,3-dioxan-5-ylidene)methyl]-2,2-dimethylpropanamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$563.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-[(2,2-Dimethyl-4,6-dioxo-1,3-dioxan-5-ylidene)methyl]-2,2-dimethylpropanamide
IUPAC NameN-((2,2-dimethyl-4,6-dioxo-1,3-dioxan-5-ylidene)methyl)pivalamide
MDL No.MFCD00794305
Molecular FormulaC12H17NO5
Molecular Weight255.27
SMILESCC(C)(C)C(NC=C1C(OC(C)(C)OC1=O)=O)=O
InChI KeyPHIILUSRIDHUHT-UHFFFAOYSA-N
SynonymN-[(2,2-dimethyl-4,6-dioxo-1,3-dioxan-5-ylidene)methyl]-2,2-dimethylpropanamide;N-[(2,2-DIMETHYL-4,6-DIOXO-1,3-DIOXAN-5-YLIDEN)METHYL]-2,2-DIMETHYLPROPANAMIDE;Propanamide, N-[(2,2-dimethyl-4,6-dioxo-1,3-dioxan-5-ylidene)methyl]-2,2-dimethyl-
CAS No.175728-10-6

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACYOET874 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACYOET874 route product structure diagram
    ACYOET874175728-10-6
Inquiry

2. ACYOET874 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACYOET874 route product structure diagram
    ACYOET874175728-10-6
Inquiry

Comments (0)